8-KThe WireRoutine
Bylaw Amendment
Filed Sep 5, 2024 · 1y ago · Accession 0000950170-24-103957
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K
- Filing date
- Sep 5, 2024
- Report date
- Aug 29, 2024
- Document
- glto-20240829.htm
- Size
- 220 KB